EIDD-2749
EIDD-2749 (4'-FlU) is an orally bioavailable ribonucleoside analog that potently inhibits viral RNA-dependent RNA polymerase (RdRp) . It demonstrates broad-spectrum antiviral efficacy in vitro and in vivo against respiratory syncytial virus (RSV), SARS-CoV-2, and lethal influenza viruses, including pandemic and highly pathogenic avian strains.
Product Specifications
CAS Number
1613589-24-4
Product Name Alternative
EIDD 2749, EIDD2749, EIDD-2749, 4'-Fluorouridine, 4'-FlU, 4'-FlU ; 4'-Fluorouridine, Antiviral, SARS-CoV-2, SARSCoV
Field of Research
Immunology & Inflammation, Infectious Disease & Virology, Protein Biochemistry
Purity
97.39% (May vary between batches)
Solubility
DMSO:15 mg/mL (57.21 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (7.63 mM) ; H2O:50 mg/mL (190.7 mM)
Smiles
O[C@H]1[C@@H] (O[C@@] (CO) (F) [C@H]1O) N2C (=O) NC (=O) C=C2
Molecular Formula
C9H11FN2O6
Molecular Weight
262.19
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Gloeobacter violaceus Glutamyl-tRNA reductase (hemA)
Recombinant Gloeobacter violaceus Glutamyl-tRNA reductase (hemA)
Recombinant Gloeobacter violaceus Glutamyl-tRNA reductase (hemA)
Recombinant Gloeobacter violaceus Glutamyl-tRNA reductase (hemA)